Mizuho Analyst Criticizes Valeant Pharmaceuticals Intl Inc And Relypsa Inc; Here’s Why
June 01, 2016 at 00:48 AM EDT
As Valeant Pharmaceuticals Intl Inc continues to face legal battles on several fronts and Relypsa Inc struggles to ramp sales of its new drug, Irina Rivkind Koffler of Mizuho explains why she remains bearish on both companies.
